Zurueck zur Suche

Reporte zur Charge UT8055JA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
2Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
IL 5 CT 1 MA 1 PA 1 OH 1 NY 1

VAERS 2725847

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

schwer
Staat
CT
Alter
32,0
Geschlecht
M
Eingang
20.12.2023
Impfdatum
02.10.2023
Beginn
20.12.2023
Tage bis Beginn
79,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Guillain-Barre syndrome Immunoglobulin therapy Muscular weakness

Symptomtext

LE weakness and mild UE hand weakness, suspected Guillain Barre Syndrome. Patient treated with 5 days of IVIG (Privigen)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Abilify, Lexapro
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2685073

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

schwer
Staat
MA
Alter
35,0
Geschlecht
M
Eingang
22.09.2023
Impfdatum
11.09.2023
Beginn
12.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Blood test Eyelid function disorder Facial paralysis Hypoaesthesia

Symptomtext

Employee received his vaccine at Clinic on Monday, 9/11/23, and the following day (9/12/23) he developed left sided numbness and facial droop. He reports having difficulty closing his left eye as well. He denies any similar sx prior to 9/12/2023. Evaluated at local ED on 9/15/23 where diagnosed with new onset Bell's Palsy. Prescribed prednisone and valacyclovir. Taking with mild symptom improvement.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Employee reports that he had blood work and had r/o CVA at outside ED on 9/15/23.
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2686475

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

moderat
Staat
IL
Alter
19,0
Geschlecht
F
Eingang
26.09.2023
Impfdatum
26.09.2023
Beginn
26.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Dyspnoea Lethargy

Symptomtext

Pt received flu vaccine at 9:15 and was under observation for 15 minutes when Sx onset began. Pt was lethargic, lightheaded and dizzy; Upon examination pt was guided to the floor and evaluated by the NP on-site. Upon examination by NP, pt was having trouble breathing, and given one dose of epinephrine. Vitals taken and monitored while a code blue was called. Pt was monitored until hand off to EMS at approximately 0940.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
WENT TO ER ON 22SEP23 FOR ENDOMETRIOSIS.
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
CANTALOUPE, STRAWBERRIES, GADOLINIUM-CONTAINING AGENTS {Class}, GADOVERSETAMIDE
Vorherige Impfungen
localized rash at site of injection

VAERS 2709434

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

mild
Staat
PA
Alter
48,0
Geschlecht
F
Eingang
03.11.2023
Impfdatum
10.10.2023
Beginn
23.10.2023
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Injection site pain Shoulder injury related to vaccine administration

Symptomtext

SIRVA, Right upper extremity pain. Proximal arm and into shoulder

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
none required
Aktuelle Erkrankungen
none reported to this provider
Vorgeschichte
none reported to this provider
Andere Medikamente
none reported to this provider
Allergien
Unasyn
Vorherige Impfungen
-

VAERS 2697200

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

mild
Staat
OH
Alter
28,0
Geschlecht
F
Eingang
17.10.2023
Impfdatum
17.10.2023
Beginn
17.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Erythema Flushing Nausea Skin warm

Symptomtext

Felt lightheaded, dizzy and nauseated. Face became flush/red and felt warm. However notes that she has felt nauseated since her miscarriage 5 days ago.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Had a miscarriage on 12 OCT 2023, just 5 days prior to receive influenza vaccine.
Vorgeschichte
1. Depression. 2. Chronic low back pain
Andere Medikamente
Cymbalta. Pre-Natal Vitamins
Allergien
Cephalosporins. Vancomycin
Vorherige Impfungen
-

VAERS 2693903

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

mild
Staat
IL
Alter
27,0
Geschlecht
M
Eingang
11.10.2023
Impfdatum
02.10.2023
Beginn
02.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error Pyrexia

Symptomtext

high temperature of 72.7F out of range for 7 weeks with no adverse event; patients were administered post excursion with no adverse event; Initial information was received on 03-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case is linked to cases US-SA-2023SA304864 and 2023SA305537. This case involves a 27 years old male patient who experienced high temperature of 72.7f out of range for 7 weeks and influenza quadrival A-B vaccine [FLUZONE QIV] were administered post excursion with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Oct-2023, the patient received a 0.5 ml, once dose of suspect influenza quadrival A-B vaccine (Suspension for injection) (lot: UT8055JA, expiry date: 30-Jun-2024 , strength: standard) via intramuscular route in unknown administration site for Immunisation. On an unknown date, high temperature of 72.7f out of range for 7 weeks with no adverse event (product storage error) (unknown Latency)and patients were administered post excursion with no adverse event (poor quality product administered) (Latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2687238

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

mild
Staat
NY
Alter
17,0
Geschlecht
F
Eingang
27.09.2023
Impfdatum
22.09.2023
Beginn
22.09.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Headache Pain Vertigo

Symptomtext

The evening of 9/22/23 pt developed a severe headache. She said it felt like a migraine but much worse. Pain level up to 9/10. Required a doctor's visit on 9/27 because she is still having the headache. She does have vertigo also. The night of the vaccine, she did have body aches and chills.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none known
Vorgeschichte
atopic dermatitis migraine gastritis excessive and frequent menstruation
Andere Medikamente
Famotidine Omeprazole Miralax Triamcinolone cream
Allergien
none
Vorherige Impfungen
-

VAERS 2721761

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge UT8055JA

gering
Staat
-
Alter
43,0
Geschlecht
M
Eingang
07.12.2023
Impfdatum
13.10.2023
Beginn
26.10.2023
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Gastric lavage Intentional overdose Suicide attempt

Symptomtext

Patient attempted suicide by ingesting half bottle of aspirin 325 mg and entire bottle of antihistamine allergy medication (Claritin) on 10/26/2023. Patient was transferred to local hospital. Patient states they pump his stomach in ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Gastric lavage
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Opioid use disorder (severe), Stimulant related disorders (severe), Schizoaffective disorder, Major depressive disorder, Anxiety disorder, PTSD, COPD, Irritable bowel syndrome, Constipation, Lower back pain, and HIV (asymptomatic).
Vorgeschichte
-
Andere Medikamente
Albuterol, Bictegravir/Emtricitabine/Tenofovir, Haloperidol, Lidocaine patch, Mometasone Furoate Inhaler, Omeprazole, Paroxetine, Senna, Mirtazapine, and Omeprazole.
Allergien
Vicodin - Anaphylaxis Bactrim - Anaphylaxis
Vorherige Impfungen
-

VAERS 2696016

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

gering
Staat
IL
Alter
46,0
Geschlecht
M
Eingang
14.10.2023
Impfdatum
03.10.2023
Beginn
03.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Poor quality product administered Product storage error

Symptomtext

temperature excursion for fluzone QIV at a high temperature of 72.7F out of range for 7 weeks with no reported adverse event; Fluzone QIV administered post temperature excursion with no reported adverse event; Initial information received on 03-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves 46 years old male patient and reporter reported temperature excursion for influenza quadrival A-B vaccine [Fluzone QIV] at a high temperature of 72.7f out of range for 7 weeks with no reported adverse event and fluzone QIV administered post temperature excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Caller reported that influenza quadrival A-B vaccine Suspension for injection at a dose of 0.5 ml total (lot UT8055JA, expiry date- 30-JUN-2024) via intramuscular route in unknown administration site for Immunization was exposed to temperature excursion being left out at room temperature at a high temperature of 72.7f out of range for 7 weeks with no reported adverse event (product storage error) (unknown latency) and On 03-OCT-2023, fluzone qiv administered post temperature excursion with no reported adverse event (poor quality product administered) (latency- same day). Action taken was not applicable. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA305541:01790050 US-SA-2023SA304864:01789997

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2695336

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

gering
Staat
IL
Alter
47,0
Geschlecht
M
Eingang
13.10.2023
Impfdatum
01.10.2023
Beginn
01.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered Product storage error

Symptomtext

FLUZONE QIV PFS at a high temperature of 72.7F out of range for 7 weeks with no reported adverse event; patients were administered post excursion with no reported adverse event; Initial information received on 03-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 47 years old male patient who was administered influenza quadrival A-B vaccine [FLUZONE QIV] post excursion at a high temperature of 72.7f out of range for 7 weeks with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Oct-2023, the patient received a dose 0.5 ml of suspect Influenza Quadrival A-B Vaccine Suspension for injection expiry date: 30-jun-2024 lot UT8055JA via intramuscular route in unknown administration site for immunization and exposed to a high temperature of 72.7f out of range for 7 weeks with no reported adverse event (product storage error) (unknown latency) and was administered post excursion with no reported adverse event (poor quality product administered) on the same day. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event fluzone qiv pfs at a high temperature of 72.7f out of range for 7 weeks with no reported adverse event and was Unknown for the event patients were administered post excursion with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA305541: US-SA-2023SA305537:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2686815

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8055JA

gering
Staat
IL
Alter
71,0
Geschlecht
M
Eingang
26.09.2023
Impfdatum
09.09.2023
Beginn
09.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

fluzone quadrivalent vaccine was administered instead of fluzone high-dose quadrivalent vaccine that was indicated with no adverse event; Initial information received on 19-Sep-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2023SA288621 (CLUSTER). This case involves a 71 years old male patient who was administered the influenza quadrival A-B vaccine [Fluzone Quadrivalent] rather than the Influenza Quadrival A-B High Dose HV Vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 09-Sep-2023, the patient received a dose 0.5 ml of suspect Influenza Quadrival A-B Vaccine Suspension for injection lot UT8055JA expiry date: not reported via intramuscular route in unknown administration site for immunisation rather than the Influenza Quadrival A-B High Dose HV Vaccine with no reported adverse event (wrong product administered) (latency same day). Action taken was unknown. At time of reporting, the outcome was Unknown for the event administered the fluzone quadrivalent vaccine rather than the fluzone high-dose quadrivalent vaccine with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-